NRXP

NRX Pharmaceuticals, Inc.

2.88 USD
+0.23 (+8.68%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NRX Pharmaceuticals, Inc. stock is down -20.44% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 6 June’s closed higher than May. 100% of analysts rate it a buy.

About NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc. develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure.